Atlas Trials

Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C

Clinical trial NCT01740089 · COMPLETED

Trial details

NCT number
NCT01740089
Sponsor
Biocad
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HepatitisHepatitis C
Start date
2011-11-01
Primary completion
2012-07-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.